Premier Holding Corp (OTCBB: PRHL) Enters Mexican markets

Orlando, FL 6/29/12 (StreetBeat) -- WEPOWER Ecolutions Inc. (the "Company"), a wholly owned subsidiary of Premier Holding Corp. (OTCBB:PRHL), an energy service provider and integrator of clean energy solutions ("WEPOWER"), is pleased to partner with Energyas Tecnoverdes S.C. ("Energyas") to distribute and install energy efficient solutions and renewable energy clean technology products and services into Mexico.

"As our world energy demand increases by 35 percent by 2030, we are faced with supply versus demand. WEPOWER Ecolutions offers solutions that create a natural and profitable alternative," said Kevin Donovan, CEO of WEPOWER Ecolutions Inc. "We are very pleased to be working closely with Energyas executing to our expansion plan in Mexico with our best-of-breed clean technology portfolio. Our timing should be well served due to the economic needs of costs savings, energy savings and increased energy production requirements in Mexico. Electricity rates in Mexico at a minimum are 6 percent higher than U.S. rates with an 8 percent annual inflation rate. Together with Energyas, WEPOWER is committed to helping corporations and municipalities in Mexico meet their energy needs."

Energyas Tecnoverdes S.C. is a preferred contractor in Mexico. With WEPOWER Ecolutions, Energyas is promoting and distributing WEPOWER solar, wind, lighting efficiency systems, lighting controls, refrigeration, HVAC and other ecolutions into their existing client base which includes a big box retailer with over 500 locations in over 130 cities in Mexico.

About WEPOWER Ecolutions Inc.

WEPOWER is a U.S. energy service company (ESCO) based in the Los Angeles area that offers renewable energy production, energy efficiency products and services to commercial middle-market companies, Fortune 500 brands, developers and management companies of large-scale residential developments. WEPOWER's business is focused as an integrator of clean-technology solutions in the U.S., with strategic expansion plans in Latin America, Asia and Europe. WEPOWER's core business delivers green solutions, branded specifically as WEPOWER "ecolutions," which include best-of-class alternative energy technology portfolio in wind turbines, solar PV power systems, green roofs, smart lighting controls, LED lighting, refrigeration systems and filters, battery storage systems, eco-friendly HVAC motors, energy and power control management systems, fuel reduction solutions for transportation and other clean technologies specific to its markets. Additional integrated business offerings include direct energy services as power purchase agreements (PPAs), energy financing and leasing of solar- and wind-powered generation programs in urban and rural real estate environments, lighting efficiency systems and refrigeration systems.

About Premier Holding Corp.

The Company provides financial and management expertise, which includes access to capital, financing, legal, insurance, mergers, acquisitions, joint ventures and management strategies, to its current subsidiary, WEPOWER. The Company also intends to acquire clean technology companies and/or green products and services that are accretive and that can be seamlessly integrated into WEPOWER, and utilize the overall economics of such products and services for the benefit of WEPOWER.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

AB InBev (NYSE: BUD) Seals $20 Billion Modelo Purchase To Gain Corona

Orlando, FL 6/29/12 (StreetBeat) -- Anheuser-Busch InBev NV (ABI), the world’s biggest brewer, agreed to buy the remainder ofMexico’s Grupo Modelo SAB for $20.1 billion in cash, gaining full control of the Corona maker to increase its presence in emerging markets.

AB InBev will pay $9.15 a share, the Leuven, Belgium-based company said today, about 30 percent more than the price of Modelo shares before talks were first disclosed on June 25. In a related deal, Constellation Brands Inc. (STZ) will buy Modelo’s stake in their U.S. distribution joint venture for $1.85 billion.

The acquisition speeds AB InBev’s push into faster-growingdeveloping countries as high unemployment and sluggish economies restrain sales in Europe and North America. Mexico’s growth exceeded Brazil’s last year as domestic consumption and exports picked up on the heels of a U.S. recovery. AB InBev, the maker of Budweiser, said it expects the combined company to deliver cost and revenue benefits of at least $600 million annually.

“The deal makes compelling strategic sense,” said Dirk Van Vlaanderen, an analyst at Jefferies International. “Adding the Corona brand to ABI’s existing global beer brand portfolio will continue to strengthen the company’s global category leadership.” Van Vlaanderen has a buy rating on the stock.

Corona Extra is the U.S.’s largest imported beer brand, ahead of nearest rival Heineken, according to data from SymphonyIRI Group, a Chicago-based market researcher.

Acquisition Multiple

AB InBev rose 3.8 percent to 61.25 euros at 3:10 p.m. in Brussels trading. Modelo gained 0.5 percent to 118.30 pesos at 8:38 a.m. in Mexico City, where the company is based. That gave the brewer a market value of 383 billion pesos ($28.6 billion).

AB InBev already owns a non-controlling 50 percent stake in Modelo, which it gained when InBev NV bought Anheuser-Busch Cos. in 2008 for $52 billion in the biggest brewing deal ever.

The acquisition price for the remaining 50 percent represents a multiple of about 16.2 times earnings before interest, tax, depreciation and amortization, according to Melissa Earlam, an analyst at UBS AG. That compares with an average multiple of 12.3 times historic Ebitda for similar deals since 1999, according to UBS estimates.

“The deal is at the high end of the expected price range,” Gerard Rijk, an analyst at ING Groep NV in Amsterdam, wrote today in an e-mail. “It’s a bit disappointing.”

The combined company will sell 400 million hectoliters of beer annually and have revenue this year of about $47 billion, according to AB InBev, which has been built up through a series of takeovers by Chief Executive Officer Carlos Brito to create a company with brands includingStella Artois and Beck’s.

Mexican Battle

The acquisition pits the world’s biggest brewer against the No. 3, Heineken NV (HEIA), in Mexico. Between them, the companies will control almost all of the country’s beer market after Amsterdam- based Heineken bought the brewing business of Fomento Economico Mexicano SAB in a deal valued at $7.7 billion in 2010. Modelo’s Mexican market share is about 60 percent, according to Lauren Torres, an analyst at HSBC Holdings Plc, and Heineken has most of the rest, with brands such as Dos Equis and Tecate.

“The biggest loser in all of this is Heineken, who now face a leaner, meaner AB InBev in Mexico,” Anthony Bucalo, an analyst at Santander in London, wrote today.

AB InBev isn’t the only brewer expanding into new markets. SABMiller Plc, the world’s second-biggest beermaker by volume, agreed to buy Foster’s Group Ltd. in Australia last year for about A$10.5 billion ($10.7 billion). Brewing assets in attractive markets are in short supply as beer makers buy each other to chase sales growth and fend off would-be suitors.

“The big asset that was sitting out there was Modelo (GMODELOC),” said Santander’s Bucalo.

Antitrust Process

The Modelo transaction is subject to regulatory approvals, AB InBev said, and the brewer will “work proactively with regulators to move through the review process efficiently.”

The sale to Constellation of Modelo’s 50 percent share in Crown Imports LLC, the joint venture that distributes Corona Extra in the U.S., means AB InBev probably won’t need to sell any U.S. brands to satisfy regulators, Richard O’Donovan, an analyst at Davy Research, said in a note.

AB InBev’s U.S. market share would have been 53.4 percent had it purchased Crown, creating a potential antitrust “stumbling block,” UBS’s Earlam wrote June 26.

The Modelo takeover, which the companies expect to close during the first quarter of 2013, “will bring our brands and proud heritage to even more consumers internationally while offering an increasing number of AB InBev’s brands in Mexico,” Modelo CEO Carlos Fernandez said in today’s statement.

Share Investment

Modelo will keep its Mexico City headquarters and Fernandez will continue to “play an important role” in running the business, along with Vice Chairman Maria Asuncion Aramburuzabala and Vice President Valentin Diez Morodo, the companies said. Two Modelo board members will join AB InBev’s board, and have committed to invest $1.5 billion in AB InBev shares.

Mexican families including that of Fernandez own a majority of a holding company that controls Modelo.

AB InBev is part-owned by a group of Brazilian investors including billionaire Jorge Paulo Lemann, Marcel Herrmann Telles and Carlos Alberto da Veiga Sicupira, who sit on the board. Three Belgian families, who founded the former Interbrew SA, also have a stake in the brewer and have board representatives.

The Budweiser maker has taken on an additional $14 billion of bank debt to fund the transaction, it said. The company, which was advised by Lazard Ltd., expects its ratio of net debt- to-adjusted Ebitda to be less than two times in 2014.

SABMiller Speculation

The Belgian brewer has cut debt from the Anheuser-Busch deal and in April agreed to buy control of the Dominican Republic’s Cerveceria Nacional Dominicana for $1.24 billion.

The sale of Modelo’s stake in Crown Imports to Constellation is expected to complete in the first quarter of 2013, the companies said. Constellation will have control of distribution, marketing and pricing for all Modelo brands in the U.S., it said. AB InBev will have the right to exercise acall option on the Modelo brands every 10 years.

Today’s deal may dampen speculation that AB InBev will seek to combine with its nearest competitor, SABMiller. (SAB) SABMiller shares fell in London trading on June 25 after it was reported that AB InBev was in talks to buy Modelo. Liberum Capital cut its recommendation on the shares to sell from hold on the grounds that speculation of a bid from AB InBev may fade.

“The much-mooted SABMiller-AB InBev merger is now off the table for a number of years,” Davy’s O’Donovan said.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Nuvilex (OTCBB: NVLX) and Singapore Subsidiary to Commercialize Cell Encapsulation Technology

Palm Beach, FL 6/29/12 (StreetBeat) -- Nuvilex, Inc. (OTCBB: NVLX), a biotechnology provider of cell and gene therapy solutions, announced today that the final Asset Purchase Agreement, as amended, has been executed and the transfer of the assets of SG Austria Pte. Ltd. to Nuvilex has begun.

Austrianova Singapore Private Limited (ASPL) and Bio Blue Bird AG (BBB) are now functioning as wholly-owned subsidiaries of Nuvilex, Inc. subject to the terms of the Asset Purchase Agreement between the companies. By acquiring the shares of ASPL and BBB, NVLX has acquired the former SG Austria assets which include, but are not limited to all licenses, IP, patents, personnel, capabilities, and facilities associated with the cell encapsulation technology for cancer treatment and all other applications. Completing this acquisition allows Nuvilex to move forward toward conducting the pancreatic cancer treatment trial and advancing its use for diabetes therapy and stem cells.

The Executive Chairman for SG Austria and ASPL, Professor Dr. Walter Gunzburg commented, "We are pleased to inform our combined shareholders and investors that activities we aimed to complete prior to this point have been accomplished. As a result, our management teams decided the timing was right to complete the transfer of assets."

SG Austria and ASPL's Chief Executive, Dr. Brian Salmons stated, "Together, we see this as an important step that increases our ability to move ahead with our collective operational goals. We anticipate announcing additional information about plans for the live cell encapsulation technology in the near future."

Dr. Robert F. Ryan, Nuvilex's Chief Executive added, "The management teams of both Nuvilex and ASPL have been working closely together and are very pleased to be able to make this transfer of assets happen. We will continue our effort to develop treatments for cancer and other diseases, and we hope to play a substantial role in the future of biotechnology and cell and gene therapy."

About Nuvilex

Nuvilex, Inc. (NVLX) is an international biotechnology provider of live therapeutically valuable, encapsulated cells and services for research and medicine. Our company's clinical offerings will include cancer, diabetes and other treatments using the company's cell and gene therapy expertise and live-cell encapsulation technology.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Microsoft (Nasdaq: MSFT) tie-up, network sale among RIM options

Palm Beach, FL 6/29/12 (StreetBeat) -- Research In Motion Ltd's (Nasdaq: RIMM) board is under mounting pressure to consider unpalatable options such as selling its network business or forming an alliance with Microsoft Corp (Nasdaq: MSFT) after the Blackberry maker again delayed the release of its next-generation smartphones, said three sources familiar with the situation.

Shares in the Canadian company, which announced a steeper-than-expected quarterly operating loss on Thursday, plunged 18 percent in extended trading, slashing its market value to $4.1 billion. The stock has fallen about 70 percent in the past year.

RIM said the launch of BlackBerry 10 mobile devices has been postponed to early 2013 - more than a year later than initially promised - because the development of its new operating system had "proven to be more time-consuming than anticipated."

The latest setback has increased pressure on RIM's board to more seriously explore other options, including measures that would amount to an admission that it cannot survive by sticking to its current strategy, said the sources, who declined to be identified because the information was confidential.

One of these options is for RIM to abandon its own operating system and adopt Microsoft's upcoming Windows 8. Microsoft CEO Steve Ballmer had approached RIM in recent months, looking to strike a partnership similar to the one the software giant has with Nokia Oyj, the sources said. Under that partnership, Nokia will use Microsoft's latest Windows operating system on its smartphones.

In such a scenario, RIM could also look for Microsoft to buy a stake in the company and fund marketing and other expenses, the sources said. However, this option is not attractive to RIM because it would mean the end of the Waterloo, Ontario-based company's technology independence, they said.

The RIM board prefers to see through the efforts to develop the new BlackBerry 10 operating system, according to the sources.
Microsoft could also be interested in RIM's wireless patents, the sources said.

RIM and Microsoft declined to comment.

Another option for RIM would be to sell its proprietary network to a private equity firm or a technology company. The buyer could then open up RIM's network operating centers to other smartphone providers, allowing them to also provide highly secured emails and other services to companies and government agencies, the sources said.

In that scenario, however, RIM's device business is seen to have no future, they said, adding that private equity firms have been considering how to separate the hardware business from the network business.

RIM has in the past considered opening up its network to rivals, under a plan led by former co-CEO Jim Balsillie. That could offer RIM a way forward as demand for its BlackBerry phones faces fierce competition from Apple Inc's iPhone and Google Inc's Android phones.

The idea would be to clearly define the network as an asset that could exist without BlackBerry handsets - an operational precursor that could have led to a possible legal split if the handset business ultimately proved untenable.

RIM is "going to have to be much more open minded to the idea that Jim Balsillie was working on before he was ousted of opening their network to third parties," said Eric Jackson, a hedge fund manager at Ironfire Capital in Toronto.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Nike (NYSE: NKE) profit hit by costs, shares fall

Palm Beach, FL 6/29/12 (StreetBeat) -- Nike Inc (NYSE:NKE) missed quarterly profit estimates for the first time in at least two years as higher spending and increased costs of materials used in its shoes and T-shirts hurt margins, while demand eased in international markets.

The results sent shares of the world's largest sportswear maker down nearly 13 percent in extended trading on Thursday.

Orders of Nike branded shoes and clothes scheduled for delivery from June through November, a closely-watched metric of demand known as "futures orders" rose 7 percent. That is less than half of the rise of futures orders in the fiscal third quarter.

In the fourth quarter that ended May 31, futures orders rose only 5 percent in Greater China, down from a 24 percent increase a year earlier, a sign that even the popular Nike "swoosh" is not immune to slowing global economic growth.

Analysts and investors have been worried about a cooling in demand as footwear trends
typically last about two to three years. Nike has been hot in the running shoe market for almost two and a half years now, said Morningstar analyst Paul Swinand.

The company earned $549 million, or $1.17 cents a share, in its fourth quarter, compared with $594 million, or $1.24 a share, a year ago.

Analysts, on average, had been expecting the company to earn $1.37 share, according to Thomson Reuters I/B/E/S.

Revenue rose 12 percent to $6.5 billion.

Gross margins fell 1.5 percentage points in the fourth quarter and have been declining for more than a year.

"While we had expected some gross margins decline and some increase in spending with the Olympics and soccer championships, both are higher than expected," said Swinand.

Swinand also said the drop in the share price could be a chance for investors to buy shares of the company, as he did not think the company has any flaws in execution.

Matt Arnold, consumer discretionary analyst for Edward Jones, saw improvement ahead for Nike.

"Margins will eventually become better and they have already taken pricing actions, so in general we think it is a matter of time. Nike is a strong brand with a lot going right for it," said Arnold.

Nike's finance chief, Don Blair, said higher input costs were the primary reason for the profit drop in the quarter. Higher prices and lower air freight expenses helped mitigate the rising materials costs.

The company also said it had more inventory than desired in China and Western Europe, raising questions about how much it would have to discount in those regions to clear off merchandise.

"There's inventory that's been piling up for quite a few quarters ...that can take a few quarters," said Canaccord Genuity analyst Camilo Lyon.

Shares of Nike, based in Beaverton, Oregon, were down 12.9 percent at $84.40 in after-hours trading on Thursday after closing at $96.89 on the New York Stock Exchange.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Victory Resources (OTCBB: VRCFF) Gets $5 Million Financing Commitment

Shawshank, VA 6/29/12 (StreetBeat) -- Victory Resources Corp. (OTCBB:VRCFF) is pleased to announce that it has entered into an agreement with GEM Global Yield Fund Limited ("GEM") for a $5.0 million CDN financing commitment. Funds raised through this facility will be used for the ongoing drill program and the subsequent engineering work to bring the Reforma mine to feasibility. Funds will also be used for the development of the Company's recently optioned Boleo property in Mexico, the Toni property located near Merritt, B.C., as well as general working capital.

Victory Resources Corp. will control the timing and maximum amount of any private placement under this agreement, and has the right, not the obligation, to drawdown on available funds. As part of the financing commitment, the Company has agreed to issue 5 million warrants to GEM in conjunction with each private placement. The warrants will be exercisable for a period of three years from the closing of each private placement at an exercise price of $0.72 CDN per share.

"We are very excited to have entered into this agreement with a world class investment group like GEM. The $5 million facility will assure that our company has access to capital beyond our current drill program," said Wally Boguski, president and CEO. "We look forward to the results of our ongoing drill program on the Reforma mine as well as the results from the drill program on the tailings pond from the historic Reforma mine operations."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Pervasip's (OTCBB: PVSP) VoX Launches Mobile Advertising Campaign with Yahoo

Shawshank, VA 6/29/12 (StreetBeat) -- Pervasip's (OTCBB: PVSP) wholly owned subsidiary, VoX Communications, a leading provider of wholesale Voice over Internet Protocol (VoIP) telephone services and cloud based computing, announced today that it has launched an advertising campaign with Yahoo (Nasdaq: YHOO). The campaign will advertise the company's mobile VoIP app targeting Android users.

Yahoo Mobile reaches 59.9 million users every month and 51% of all US mobile users. They are #1 in finance and entertainment and #2 in search, instant messaging, news, sports and mail. The campaign will highlight the app's many value propositions to the consumer including free VoX to VoX calling, low cost international plans, roaming avoidance and Wi-Fi calling.

"Yahoo's reach is vast in the market, which is why we chose to advertise with them and feel this is the campaign we need to drive sales of our app. Their mobile advertising network will allow us to learn from users who click our ads and properly attract similar users during the campaign," said Barry MacCheyne, CMO of VoX Communications. "We already have a high conversion rate of consumers who are finding our app in the Google Play store and hope this initiative has the potential to grow our user base exponentially to new levels."

VoX has 70,000 downloads of its app from the Google Play store, with over 700 reviews and an average rating of 4.6 stars. This campaign will be the first time the company has made a significant investment to advertise its app.

About VoX Communications:

VoX Communications delivers mobile VoIP and video telephone services through cloud computing. It recently entered the mobile VoIP services and applications arena so that its VoIP can utilize any 3G/4G or WiFi connection. VoX differentiates itself through a unique combination of high quality voice services, flexible back-office capabilities and automated provisioning systems that enable a quick turn-up for app users who are looking for a second mobile phone line or low-cost international calling, without using any voice-plan minutes from their mobile phone carrier. It offers a feature-rich, low-cost, high-quality alternative to traditional wireless phone services. For more information, please visit www.voxcorp.net.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Explore Anywhere Holding (OTCBB: EAHC) Announces Senior Lender Debt Reduction

Northern, WI 6/29/12 (StreetBeat) -- Explore Anywhere Holding Corp. (OTCBB: EAHC), specializing in developing computer monitoring solutions for parents, corporations, and educational facilities, is pleased to announce the reduction of one hundred thousand dollars ($100,000) of long-term debt.

In the ongoing effort to improve corporate structure, Explore Anywhere successfully negotiated the reduction of one hundred thousand dollars of debt from its balance sheet. The reduction accounts for approximately twenty percent of the company's total debt. "In a vote of confidence, our senior lender has agreed to convert a significant portion of debt to equity," said Explore Anywhere's CEO Bryan Hammond. Mr. Hammond continued, "Strengthening the balance sheet coupled with last month's retirement of 14,000,000 shares makes our company much stronger financially. We look forward to sharing other major corporate initiatives with investors and capital markets as we progress to address the need for safer use of today's increasingly mobile world."

About Explore Anywhere Holding Corp.
Explore Anywhere specializes in computer monitoring solutions for parents, corporations, and educational facilities. Explore Anywhere's mission is to provide effective and useful computer monitoring products at affordable prices in an effort to cut down on the dangers of the Internet and the greater community at large. Its solutions implement technologies designed to address a range of emerging online threats.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Phototron (OTCBB: PHOT) to Capitalize on Medical Marijuana Entertainment Industry

Northern, WI 6/29/12 (StreetBeat) -- Phototron Holdings, Inc. (OTCBB: PHOT), a leading technology supplier to the hydroponic growing industry, yesterday announced the formation of a new business unit to enhance its commitment to "Live to Grow, Grow to Live". GrowLife Productions, Inc. will focus on business opportunities in the entertainment and lifestyle market surrounding the medicinal cannabis industry.

Phototron Holdings may be best known for its portfolio of home gardening technologies, but it's also building a strong position in the medicinal marijuana industry. With co-sponsorships of major industry entertainment events, select celebrity associations, and high tech equipment brands, the company aims to foster a growing community around its products. GrowLife Productions will also head up the company's mobile and Facebook gaming activities, as it relates to our industry.

"As a company we are uniquely positioned to participate in the lifestyle and culture of an industry that sees genuine value in medicinal marijuana products," said Sterling Scott, CEO of Phototron Holdings Inc. "We expect our GrowLife Productions business unit to immediately contribute to the industry and drive significant revenue enhancement and profit opportunities for our company. The investment community can expect more detailed announcements and further definition of focus of GrowLife Productions throughout the balance of 2012."

About Phototron Holdings, Inc.

Phototron Holdings, Inc. (PHOT) is a progressive company with core holdings in innovative technology based products and services for home gardening specialty markets including Stealth Grow LED brand LED grow lights and the Phototron single plant systems and accessories.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Aperture Health (OTCBB: APRE) Looks to Leverage the Service Offerings of Docs on Call

Northern, WI 6/29/12 (StreetBeat) -- Aperture Health, Inc. (OTCBB: APRE) announced yesterday that Comprehensive Geriatric Medicine, P.C., which is doing business as Doctors on Call, and was selected by the Centers for Medicare and Medicaid Services ("CMS") as one of only sixteen (16) private medical practices nationwide to participate in the Independence At Home Demonstration program ("IAHDP"), is likely to become the driving force behind revenue generation for the company post merger. IAHDP was envisioned and deployed as part of the Patient Protection and Affordable Care Act, intended to assign the medical practice greater accountability for all aspects of patient care at home. Private medical practices chosen by CMS to participate in IAHDP will be monitored for maintaining quality care standards and reducing overall healthcare costs associated with the patients enrolled in the program.

Doctors on Call, led by physicians along with nurse practitioners will provide primary care visits at patient homes, particularly those with multiple chronic conditions and functional limitations. With a focus on providing timely and appropriate care in order to improve quality of care and quality of life for patients; while lowering care costs via maintaining the patient at home for as long as possible.

Dr. Paul Rosenstock, MD, Doctors on Call's CEO, has led the company to become a premier provider of private medical services to patients at home, currently generating $2,000,000.00 in annual revenues with a history of rapid revenue and profit growth year over year. Additionally, the company is near completion of its first Diagnostic Urgent Care Private Practice Site, which the company's management projects will help the company reach a projected revenue milestone of over $14,000,000.00 in eighteen (18) months from start up. With plans for at least two (2) additional such sites coupled with the services of Triad Therapeutics, Aperture's wholly owned home infusion subsidiary, Dr. Rosenstock envisions a very strong future for both entities.

James Hennig, R.Ph, Aperture's CEO and Chairman of the Board of Directors, reiterated and added, "By combining the clinical and business management expertise of Aperture Health and Doctors on Call, we open additional pathways to medical and pharmaceutical service offerings to homecare patients throughout the NY and NJ areas. Joining forces will allow for a more seamless 'transition of care' process for patients from comprehensive physician evaluation through the initiation of pharmaceutical care at home. We anticipate greater leveraging of each subsidiaries' core competency in an effort to accelerate revenue generation and profitability."

About Aperture Health, and Triad Therapeutics
Aperture Health through its wholly owned subsidiary Triad Therapeutics operates a fully JCAHO accredited home IV therapy company, achieving this "gold standard" status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the States of New Jersey, New York and Connecticut, providing opportunity for organic growth. Patient referrals are made from physicians, hospitals, insurance companies, veterinarians and hospice care providers that have established a professional rapport with Triad.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Genius Brands (OTCBB: GNUS) Sees Bright Future for Baby Genius(R) Brand

Atlanta, GA 6/29/12 (StreetBeat) -- 2012 has been tough on many small cap companies –as well as many big board plays – but a down market can provide value opportunities. After reporting revenue that slid more than 20 percent in the first quarter of 2012 as compared to the same period in 2011, Genius Brands International, Inc. (OTCBB:GNUS), a developer and marketer of entertainment products including the award winning Baby Genius® line of music and education-based products and characters, could be a company to keep an eye on in the second half of the year for numbers that start topping last year’s figures.

The reasoning is really pretty simple. Sales dipped from $1.31 million to $1.03 million in the first quarter of 2012 as compared to Q1 2011 because of the termination of a toy licensing deal with Battat Incorporated and subsequent royalty payments falling short of the year prior quarters. The nearly $400,000 that was missing from Q1 2012 because of the Battat deal being over was partially offset by Genius Brands actually boosting product sales by 12 percent, or $107,959, during the quarter.

Genius Brands has now inked a new licensing deal with JAKKS Pacific’s (Nasdaq:JAKK) Tollytots® division which is scheduled to launch a line of 20 toys by the third quarter 2012. The upcoming revenue from JAKKS could dwarf the deal with Battat in the mid-term.

Further, Genius Brands reduced their debt load substantially in the first quarter as four members of the management team converted their long term-subordinated notes to the Company in the total amount of $1,572,161 into equity. These moves decreased the company's long term debt by 80% from $2,143,178 in the period ended December 31, 2011 to $429,687 in the quarter ended March 31, 2012. Total equity on March 31, 2012 was $86,572 compared to $(1,120,633) on December 31, 2011, an increase of $1,207,205.

Today, Genius Brands again increased its future potential by signing a new licensee agreement with Sunscape Eyewear, a 17-year old eyewear company that has grown from a small retail operation to an internationally known brand with a presence in Los Angeles, New York, London and Milan.

The two-year agreement, which is slated to debut during the 2012 holiday season, grants Sunscape rights to manufacture and distribute worldwide Baby Genius®-themed eyewear for boys and girls ages 0-4 years featuring the beloved Baby Genius® characters. Product categories include sunglasses, eyewear and eyewear accessories such as croakies and cases. High profile retailers such as Walmart (NYSE:WMT), Toys 'R' Us, Babies 'R' Us and Target (NYSE:TGT) will be carrying the brands, which should certainly bolster sales during the busiest shopping season of the year for Genius Brands.

"The brand enthusiasm that children have for Baby Genius® characters will help drive demand for these new Sunscape sunglasses. Baby Genius® DVDs and CDs are currently sold at some of the mass retailers that carry Sunscape eyewear, creating a growing line of Genius branded products in the nation's largest stores," said Genius Brands Chairman and CEO, Klaus Moeller.

With JAKKS kicking-off the fall season for Genius Brands and the follow-up by Sunscape in the fourth quarter, it should be anticipated that Genius Brands could post record numbers in the second half of 2012 and into 2013.

At the opening bell today, Genius Brands had a market cap of around $12 million, which could be deemed as an undervalued proposition considering the recent moves to minimize debt and the deal with JAKKS. Bringing the new agreement in with Sunscape, shares have edged higher in today’s trading by 11.45% to $0.185 per share, which is still well below the 28 cent mark that shares hit around this time in June 2011. A quiet company that is generally thinly-traded, investors may want to take a closer look at where Genius Brands could be in another six or nine months. Proper due diligence is, as always, encouraged.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Aeterna Zentaris (Nasdaq: AEZS) Initiates Phase 1 Trial in Multiple Myeloma in Japan

Atlanta, GA 6/29/12 (StreetBeat) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) today announced that its Japanese partner Yakult Honsha ("Yakult") has initiated a Phase 1 trial in multiple myeloma, a form of blood cancer, with perifosine, the Company's oral Akt/PI3K inhibitor drug. Yakult, who are sponsoring and conducting this trial in Japan , reported that a first patient has been treated with perifosine.

This is an open-label, two step Phase 1 trial in which perifosine is combined with bortezomib (Velcade®) and dexamethasone in patients with refractory multiple myeloma who had previously been treated with bortezomib. The trial is expected to include a total of 18 patients (6 in step 1 and 12 in step 2). Patients will receive perifosine daily (50 mg, Days 1-21) in combination with bortezomib (1.3 mg/m2, Days 1, 4, 8 and 11) and dexamethasone (20 mg, Days 1, 2, 4, 5, 8, 9, 11 and 12) according to a three-week cycle (21 days ± 3 days). The primary endpoint is safety while secondary endpoints include response rate, progression-free survival, and time to tumor progression.

Juergen Engel, PhD, President and CEO at Aeterna Zentaris stated, "We would like to thank our partner Yakult for their close collaboration in initiating this important Phase 1 trial in multiple myeloma which is necessary at this time in order to comply with Japan's specific registration requirements. Perifosine, also currently in a Phase 3 trial in other parts of the world in multiple myeloma for which we expect to reach an interim analysis in the first quarter of next year, remains a key component of our deep pipeline focused on providing novel, targeted treatment options for cancer patients facing unmet medical needs".

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Know Before Trading

Atlanta, GA 6/29/12 (StreetBeat) -- Stocks were strong in Asian trade. The Hang Seng was among the best with a gain of more than two percent and the Nikkei rose one and a half percent, while Shanghai and Australia both added more than one percent. European indexes are very well bid this morning, with the Footsie better by one and a half percent, the Dax up more than two and a half percent and Spain better by about three percent. US stock futures are up by one percent or more.

*The May reading of Japan’s Jobless Rate is 4.6%, down two tenths from the month before and one tenth below the forecast.

*The May reading of Japan’s Consumer Price Index ex-fresh food is -0.1% year on year; a tenth under the estimate and down from +0.2% in April. The June reading of that same inflation measure for Tokyo is -0.6% year on year, but that is one tenth less deflationary than expected.

*The preliminary May reading of Japanese Industrial Production is -3.1% month on month, three tenths worse than expected.

*The euro zone announced that they plan on using EFSF/ESM funds to directly support Spanish banks and these loans will not carry senior status. The EU will additionally take steps on establishing a banking union, with preliminary structure for that to be announced in a few months time. As is usually the case with these summit generated plans there is a shortage of available details. Some are significant, such as: the ESM still needs to be ratified by all of the euro area parliaments. Merkel has reiterated her resistance to euro bonds and she must convince her Bundestag that the direct funding of the banks is not a radical departure from the already established ESM guidelines.

*The May reading of German Retail Sales is -0.3% on a monthly basis, missing the forecast for a monthly gain of 0.2%.

*The April reading of Canada’s GDP is due out at 7:30am CDT, it is expected to be +0.2% on a monthly basis and +1.8% year on year.

*The May reading of Personal Income and Spending is due out at 7:30am CDT. Spending is expected to be +0.2% on the month and the estimate for Spending is 0.0% month on month. The headline PCE inflation measure, the Fed’s benchmark, is expected to be 1.5% year on year, down from 1.8% the month before. The Core PCE is forecast to be +0.2% month on month and +1.8% annualized. The June reading of the Chicago Purchasing Managers Index is due out at 8:45am CDT, but three minutes earlier for the subscribers; it is expected to be 52.3, down just a fraction from the month before. The final June reading of consumer sentiment from the University of Michigan is set to be released at 8:55am CDT, it is forecast to be 74.1, or unchanged from this month’s preliminary result.

*The Fed is scheduled to buy Treasuries today that are due to mature between 6/30/18 and 5/15/20; the results of the operation will be announced just after 10:00am CDT. Later on, at 1:00pm CDT, the NY Fed will release next month’s Operation Twist schedule.

*There is a bit of Fed speak on the calendar today, including: NY Fed boss Dudley at 7:30am CDT and St. Louis Fed’s Bullard at 8:05am CDT.

StreetBeat Disclaimer

Distributed by Viestly

What the Supreme Court's Ruling Means for Consumers

Atlanta, GA 6/28/12 (StreetBeat) -- The Supreme court said Congress was acting within its powers under the Constitution when it required most Americans to carry health insurance or pay a penalty. It upheld the mandate as a tax, in an opinion by Chief Justice John Roberts.

But the justices found fault with part of the health-care law's expansion of Medicaid, a joint federal-state insurance program for the poor. The justices made some changes to the Medicaid portion of the law.

Q: Does this mean the health overhaul law is in place for good?

A: The decision effectively upholds the law for now, but its future depends on which party controls the White House and Congress after elections in November. President Barack Obama and most Democrats consider the law a signature achievement and want to move forward implementing it. Republicans, including presumptive presidential nominee Mitt Romney, have pledged to overturn it. They say they would offer an alternative proposal but haven't been specific about what it would include.

Q: What happens to any benefits I already get because of the law?

A: They will stay in place for now. Parents will still be able to keep their children on their insurance plans up to age 26, and Medicare recipients will keep getting discounts on prescription drugs to close a gap in coverage known as the "doughnut hole." New levies under the law, such as the 10% tax on tanning services, also stay put.

Q: When will I see the big changes from the law?

A: Most of the mandates don't start until 2014. That is when most Americans will be required to carry insurance or pay the penalty at issue in the Supreme Court case. The penalty will start at $95 a year or up to 1% of a person's income, whichever is greater.

Tens of millions of Americans are expected to get insurance coverage under the system that starts in 2014. Some of the poorest Americans will become newly qualified to enroll in the federal-state Medicaid program—although the court appeared to make some changes to how that program will work. Another batch of people who earn more but still have low incomes will get tax credits to offset their insurance costs. Consumers will be able to comparison shop for policies in newly created exchanges that will operate like popular online travel websites.

Insurance companies will have to sell coverage to everyone, regardless of their medical history, and will have to restrict how much they vary premiums based on age. Companies with 50 workers or more will be required to offer insurance to their workers or pay a penalty.

Q: What if I already have insurance?

A: You may see changes to your plan. Unless your employer has "grandfathered" your insurance benefits' structure, your plan will have to meet new regulations under the law, such as covering more preventive services without out-of-pocket costs. There has been speculation that some employers will stop offering coverage and funnel workers toward exchanges once they open, but most companies say they have no immediate plans to do that.

Q: What will happen to my insurance premiums?

A: Most consumers can expect to keep seeing increases in premiums and co-payments because the underlying cost of health care is expected to rise. The law contains a few mechanisms to curb premiums, but it also requires that many insurance providers make their benefits more generous, which will raise their cost. Older people could see their premiums go down because of the new age rating rules insurers will face. People who buy policies without the help of an employer could get a better deal by being able to shop on the exchanges, where comparing plans will be easier than before.

StreetBeat Disclaimer

Distributed by Viestly

Active Health Foods (OTCBB: AHFD) Announces GNC Agreement

Atlanta, GA 6/28/12 (StreetBeat) -- Active Health Foods, Inc. (OTCBB:AHFD), the maker of "Active X™" 100% Organic Certified, 100% Natural, Kosher and Vegan Certified Energy Bars announces that General Nutrition Centers, Inc., commonly known as GNC, has agreed to do a 600 store test, all of their "A" LIST STORES, in two flavors of the Active X™ Energy Bars, Peanut Butter Chocolate Joy and Almond Chocolate Delight.

General Nutrition Centers, Inc. (NYSE:GNC), started in 1935 and based in Pittsburgh, Pennsylvania, has as its primary focus the retail sales of healthy and nutritious products including vitamins, supplements, minerals, herbs, sports nutrition, diet and energy products. GNC has over 6,000 corporate owned and franchised stores nationwide and is widely considered the premier health store chain in the United States.

"Our agreement with GNC for our Active X™ Almond Chocolate Delight and Peanut Butter Chocolate Joy Energy Bars represents a monumental opportunity for Active Health Foods, Inc," said Greg Manos, President and Chief Executive Office of Active Health Foods Inc., who added, "Active Health Foods, Inc. is looking forward to building on this success and further expanding our exposure to the public through the thousands of GNC outlets."

Active X™ Energy Bars may be purchased at Amazon.com (Nasdaq: AMZN) and leading retail outlets such as Sheetz, Inc. and Scolari's Food and Drug.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Latest Drug Trial Data Pounds Vertex Pharma (Nasdaq: VRTX) Shares

Shawshank, VA 6/28/12 (StreetBeat) -- Vertex Pharmaceuticals (Nasdaq:VRTX) tumbled more than 10% in heavy trading early Thursday after the company reported positive trials results that were nonetheless not quite what investors were hoping for.

The company reported data on a phase-two study of cystic fibrosis patients taking Vertex's Kalydeco along with experimental drug candidate VX-809. The study found a 6.7% improvement in lung function after 56 days of treatment, slightly better than what Wall Street expected, according to ISI Group analyst Mark Schoenebaum. But he added that the results were only for the highest-dose group, whereas investors had been hoping for pooled data of all groups. Also, the responder data was not strictly comparable with the previously released interim data on the study.

"Thus, although the 'responder data' LOOK BETTER in the final analysis at the high dose than in the interim data, we would advise caution on over-interpreting this comparison," Schoenebaum wrote in a email to clients.

Investors seemed to take this heart, perhaps because they'd been burned before. In May the stock soared on strong data from the same trial, only to fall again when the companyrestated its results due to a statistical error.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Tahoe (NYSE: TAHO) denies Guatemala proposed mine act changes

Shawshank, VA 6/28/12 (StreetBeat) -- Shares of Tahoe Resources Inc (NYSE: TAHO) tumbled on Thursday even as it denied media reports that Guatemala was considering legislation that would allow it to take up to 40 percent of companies exploiting natural resources there.

"We have not been contacted by the Guatemalan government regarding this," said Ira Gostin, Tahoe's vice president of investor relations. "There hasn't been anything actually passed in the Guatemalan law or anything proposed."

Shares of the silver miner had been halted Thursday morning on the Toronto and New York stock exchanges.

By 11 a.m. (1500 GMT), the company's Toronto-listed shares were down 39.7 percent at C$9.75, while its New York-listed shares fell 23.7 percent to $12.05.

A report on Mineweb.com said Guatemala, where Tahoe is developing the Escobal silver mine, had proposed changes to its mine act to acquire up to 40 percent of mining companies with operations in the Central American country. The original source of the report was a local newspaper.

Representatives of the Guatemalan government could not be reached immediately for comment.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

BrightPoint (Nasdaq: CELL) Announces Logistic Services Relationship With FreedomPop

Northern, WI 6/28/12 (StreetBeat) -- Brightpoint, Inc. ("BrightPoint") (Nasdaq:CELL), a global leader in providing device lifecycle services to the wireless and high-tech industries, today announced that its subsidiary, Brightpoint North America L.P. ("BrightPoint Americas"), has entered into a logistic services relationship with FreedomPop, the innovative new mobile broadband company.

In conjunction with the relationship, BrightPoint Americas will provide a variety of critical logistic services including inventory management, kitting, packaging, transportation management, order fulfillment and reverse logistics.

"We are pleased to work with BrightPoint Americas, a proven leader in logistics who can support the aggressive growth projections we have," said Steven Sesar, FreedomPop's Chief Operating Officer. "This relationship enables FreedomPop to benefit from BrightPoint's extensive logistics expertise and proven device lifecycle services and will provide our customers with prompt fulfillment and delivery of FreedomPop devices."

"We are excited to support FreedomPop and their mission to provide innovative wireless broadband products to consumers," stated J. Mark Howell, BrightPoint's President Americas. "BrightPoint's scalable, customized services platform will accelerate the availability of FreedomPop's innovative products which will utilize Clearwire's 4G network to provide wireless internet service to consumers."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Orexigen (Nasdaq: OREX) rallies after FDA approves competing obesity drug

Northern, WI 6/28/12 (StreetBeat) -- Anti-obesity drug maker Orexigen (Nasdaq:OREX) is climbing after another company, Arena Pharmaceuticals (Nasdaq:ARNA), received FDA approval for its anti-obesity drug, Lorcaserin, yesterday afternoon. In a note to investors earlier this morning, research firm JMP Securities wrote that the FDA's approval of Lorcaserin suggests that the agency sees the need for an effective anti-obesity drug. The FDA's position on this matter could benefit Orexigen, said the firm, which thinks that the company offers the best value in the anti-obesity space.

The firm reiterated an $8 price target and Outperform rating on Orexigen. Meanwhile, JP Morgan reacted to the FDA's approval of Arena's Lorcaserin by upgrading shares of Orexigen this morning to Overweight from Neutral with a $10 target. In early trading Orexigen jumped 67c, or 13.62%, to $5.59.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Synergetics (Nasdaq: SURG) shares jump on nod for eye surgery device

Palm Beach, FL 6/28/12 (StreetBeat) -- Shares of Synergetics USA Inc (Nasdaq: SURG) jumped nearly 50 percent on Thursday after U.S. health regulators granted marketing approval for the company's eye surgery device.

The U.S. Food and Drug Administration on Wednesday approved VersaVIT - a device to remove liquid from inside the eye during a surgery.

The company said it was waiting for a similar approval from European health authorities.

Synergetics shares, which have lost nearly 50 percent of their value so far this year, touched a more than one-month high of $5.75 in early trading. The company's stock was the top percentage gainer on the Nasdaq.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Obamacare's Insurance Rule Is Upheld by Supreme Court

Palm Beach, FL 6/28/12 (StreetBeat) -- The Supreme Court, in a landmark ruling Thursday, upheld the individual insurance requirement at the heart of President Barack Obama's health care overhaul.

The court on Thursday handed Obama a campaign-season victory in rejecting arguments that Congress went too far in requiring most Americans to have health insurance or pay a penalty.

Chief Justice John Roberts announced the court's judgment that allows the law to go forward with its aim of covering more than 30 million uninsured Americans.

The court, however, found problems with the law's expansion of Medicaid, but even there said the expansion could proceed as long as the federal government does not threaten to withhold states' entire Medicaid allotment if they don't take part in the law's extension.

The court's four liberal justices, Stephen Breyer, Ruth Bader Ginsburg, Elena Kagan and Sonia Sotomayor, joined Roberts in the outcome. Justices Samuel Alito, Anthony Kennedy, Antonin Scalia and Clarence Thomas dissented.

Stocks of hospital companies moved sharply higher on the decision, including HCA Holdings (HCA) and Community Health Systems (CYH).

Stocks of drug companies and medical device makers are slightly lower for the day as analysts sort through the Supreme Court's ruling. Stocks of the biggest insurance companies are also lower.

The ruling on Obama's sweeping federal health care law will shape the contours of the presidential campaign through the summer and fall. Both Obama and Republican rival Mitt Romney are primed to use the outcome for political gain.

Before the decision, Obama has expressed confidence the court will uphold his signature legislative initiative.

Obama recently avoided mentioning the impending court ruling directly, but he has vigorously defended the health-care overhaul as critical to the public's health and well-being in campaign events this week.

"I think it was the right thing to do. I know it was the right thing to do," he told supporters in Boston.

Romney, who as Massachusetts governor signed a health care law on which the Obama's federal law was modeled, has focused more than usual on the Supreme Court ruling this week.

Polling suggests that most Americans oppose the law, but an overwhelming majority want Congress and the president to find a new remedy if it's struck down. Romney so far has spent little time crafting a comprehensive plan to replace the overhaul.

And the Obama campaign already has seized on Romney's opposition to the most popular provisions in the law. For example, Romney would not prevent health-care companies from denying coverage to new customers with medical conditions. Nor would he force them to cover young adults on their parents' plans through age 26.

Still, both sides will use it to raise money and motivate supporters.

And outside groups are ready to unleash a flood of advertisements following the ruling, including a 16-state, $7 million ad buy from the conservative political action group Americans for Prosperity.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

News Corp (NSQ:NWSA) confirms plan to split in two

Palm Beach, FL 6/28/12 (StreetBeat) -- Rupert Murdoch's News Corp (NSQ:NWSA) said on Thursday it would pursue splitting the $60 billion media conglomerate into separate publicly traded publishing and entertainment companies.

Murdoch will be chairman of both companies and will be chief executive of the entertainment business. The company did not name a chief executive for the new publishing company.

News Corp's board, overseen by the 81-year-old Murdoch, met on Wednesday and authorized management to move ahead with the separation, the company said.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

JPMorgan (NYSE: JPM) Trading Loss May Reach $9 Billion

Orlando, FL 6/28/12 (StreetBeat) -- Losses on JPMorgan Chase's (NYSE: JPM) bungled trade could total as much as $9 billion, far exceeding earlier public estimates, according to people who have been briefed on the situation.

When Jamie Dimon, the bank's chief executive, announced in May that the bank had lost $2 billion in a bet on credit derivatives, he estimated that losses could double within the next few quarters. But the red ink has been mounting in recent weeks, as the bank has been unwinding its positions, according to interviews with current and former traders and executives at the bank who asked not to be named because of investigations into the bank.

The bank's exit from its money-losing trade is happening faster than many expected. JPMorgan previously said it hoped to clear its position by early next year; now it is already out of more than half of the trade and may be completely free this year.

As JPMorgan has moved rapidly to unwind the position - its most volatile assets in particular - internal models at the bank have recently projected losses of as much as $9 billion. In April, the bank generated an internal report that showed that the losses, assuming worst-case conditions, could reach $8 billion to $9 billion, according to a person who reviewed the report.

With much of the most volatile slice of the position sold, however, regulators are unsure how deep the reported losses will eventually be. Some expect that the red ink will not exceed $6 billion to $7 billion.

Nonetheless, the sharply higher loss totals will feed a debate over how strictly large financial institutions should be regulated and whether some of the behemoth banks are capitalizing on their status as too big to fail to make risky trades.

JPMorgan plans to disclose part of the total losses on the soured bet on July 13, when it reports second-quarter earnings. Despite the loss, the bank has said it will be solidly profitable for the quarter - no small achievement given that nervous markets and weak economies have sapped Wall Street's main businesses. To put the size of the loss in perspective, JPMorgan logged a first-quarter profit of $5.4 billion.

More than profits are at stake. The growing fallout from the bank's bad bet threatens to undercut the credibility of Mr. Dimon, who has been fighting major regulatory changes that could curtail the kind of risk-taking that led to the trading losses. The bank chief was considered a deft manager of risk after steering JPMorgan through the financial crisis in far better shape than its rivals.

"Essentially, JPMorgan has been operating a hedge fund with federal insured deposits within a bank," said Mark Williams, a professor of finance at Boston University, who also served as a Federal Reserve bank examiner.

A spokesman for the bank declined to comment.

In its most basic form, the losing trade, made by the bank's chief investment office in London, was an intricate position that included a bullish bet on an index of investment-grade corporate debt. That was later combined with a bearish wager on high-yield securities.

The chief investment office - which invests excess deposits for the bank and was created to hedge interest rate risk - brought in more than $4 billion in profits in the last three years, accounting for roughly 10 percent of the bank's profit during that period.

In testimony before the House Financial Services Committee last week, Mr. Dimon said that the London unit had "embarked on a complex strategy" that exposed the bank to greater risks even though it had been intended to minimize them.

JPMorgan executives are briefed each morning on the size of the trading loss. The tally could shrink if the market moves in JPMorgan's favor, the people briefed on the situation cautioned.

But hedge funds and other investors have seized on the bank's distress, creating a rapid deterioration in the underlying positions held by the bank. Although Mr. Dimon has tried to conceal the intricacies of the bank's soured bet, credit traders say the losses have still mounted.

While some hedge funds have compounded the bank's woes, others have been finding it profitable to help JPMorgan get clear of the losing credit positions.

One such fund, Blue Mountain Capital Management, has been accumulating trades over the last couple of weeks that might help reduce the risk of the bets made by JPMorgan in a credit index, according to interviews with more than a dozen credit traders. The hedge fund is then selling those positions back to the bank. A Blue Mountain spokesman declined to comment.

As traders in JPMorgan's London desk work to get out of the huge bet, which started generating erratic losses in late March, the traders based in New York are largely sitting idle, according to current traders in the unit.

"We are in a holding pattern," said one current New York trader who asked not to be named.

Long before the losses started mounting, senior executives at the chief investment office in New York worried about the trades of Bruno Iksil, according to the current traders.

Now known as the London Whale for his outsize wagers in the credit markets, Mr. Iksil accumulated a number of trades in 2010 that were illiquid, which means it would take the bank more time to get out of them.

In 2010, a senior executive at the chief investment office compiled a detailed report that estimated how much money the bank stood to lose if it had to get out of all Mr. Iksil's trades within 30 days. The senior executive recommended that JPMorgan consider putting aside reserves to deal with any losses that might stem from Mr. Iksil's trades. It is not known how much was recommended as a reserve or whether Mr. Dimon saw the report, but the warning went unheeded.

The losses are the most embarrassing fumble for Mr. Dimon since he became chief executive in 2005.

In appearances before Congress, Mr. Dimon has taken pains to assure investors and lawmakers that the overall health of JPMorgan remained strong and that it had more than sufficient amounts of capital to weather any economic dislocation.

Even as he apologized for the trade, calling it "stupid," Mr. Dimon emphasized to lawmakers that the loss was an "isolated incident."

The Federal Reserve is currently poring over the bank's trades to examine the scope of the growing losses and the original bet.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Hospital stocks jump after health care ruling

Orlando, FL 6/28/12 (StreetBeat) -- Stocks of hospital companies are moving sharply higher after initial reports said the Supreme Court upheld the individual insurance requirement in President Barack Obama's health care overhaul.

HCA Holdings stock is up 10 percent. Community Health Systems is also up 10 percent.

Stocks of drug companies and medical device makers are slightly lower for the day as analysts sort through the Supreme Court's ruling. Stocks of the biggest insurance companies are also lower.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

3 Things to Know Before Trading

Orlando, FL 6/28/12 (StreetBeat) -- Stocks were mixed in Asian trade. The Nikkei was among the best with a gain of 1.65%, but Australia was unchanged and the Hang Seng fell 0.8% and Shanghai was about one percent lower. European indexes are also mixed this morning but the Dax and Footsie are both down one percent and three quarters of a percent respectively. US stock futures are down about a third of a percent as I write.

*The May reading of Japanese Retail Trade is +0.7% month on month, more than triple the expected gain.

*The final June reading of the Euro Zone Consumer Confidence was revised lower by two tenths to -19.8.

*The June reading of Germany’s Unemployment Rate is 6.8%, steady from the month before but that result was revised up by one tenth. The net change in the number of unemployed is +7k, but was forecast to be +3k.

*European leadership is set to arrive at their summit in Brussels beginning at 7:15am CDT. The occasional “out of the blue” newswire headline is possible at any time, such as: Merkel says EMU growth package is at the center of today’s agenda and EU source says summit to debate emergency aid to Spain and Italy and Finnish PM says no miracles at summit, must stick to rules.

*UK house prices fell 0.6% on a monthly basis in June, according to Nationwide; a one tenth increase was expected.

*The final reading of the UK Q1 GDP was unrevised at -0.3% on a quarter on quarter basis, but was revised down one tenth to -0.2% on a year on year basis.

*The Supreme Court ruling on the ObamaCare case is expected this morning.

*The weekly report on Initial Jobless Claims is due out at 7:30am CDT, it is expected to be 385k. The final reading of Q1 GDP is also due out at 7:30am CDT; no changes from the previous report are expected: GDP +1.9%; Personal Consumption +2.7%; Price Deflator +1.7%.

*The weekly report on inventories of Natural Gas is due out at 9:30am CDT, it is expected to show an increase of 53 bcf.

*The June reading of the Kansas City Fed Manufacturing Activity Index is due out at 10:00am CDT, it is forecast to be 4; it was 9 in May.

*The Fed is scheduled to sell Treasuries today that are due to mature between 11/15/14 and 6/15/15; the results of the operation will be announced just after 10:00am CDT.

*The Treasury plans to sell $29 billion 7 Year Notes today; the auction results will be announced just after noon CDT.

*There are a couple of Fed speakers on the calendar today, including: Cleveland Fed’s Pianalto at 10:30am CDT and Dallas Fed boss Fisher at 6:00pm CDT.

StreetBeat Disclaimer

Distributed by Viestly

Entropic Sommunications (ENTR) is Sending a Clear Message

Northern,WI 6/27/2012 (TradersCorner) -- TradersCorner: Entropic Communications Inc (Nasdaq: ENTR) has revised its expected outlook for the second quater sending its shares up over 20% percent in morning trading. Full Disclaimer Here

Distributed by Viestly

Hackers Are Not the Only Ones Robbing You

Orlando, FL 6/27/12 (StreetBeat) -- StrikeForce Technologies, Inc. (OTCBB:SFOR), creators of two factor out-of-band authentication and anti-keylogging keystroke encryption, is calling for the business and technology world to wake up.

Week after week of reported security breaches, in our opinion, have not gotten businesses to reevaluate the methods they use to prevent these now routine occurrences. The latest example was illustrated by a team of scientists that produced a research report explaining how they extracted a key from an RSA token in just thirteen minutes, as published by the New York Times on June 26, 2012.

Just a few days ago another troubling report was published by the University of Alabama-Birmingham showing that the leading anti-virus vendors were only able to prevent 25% of the password stealing and remote control Trojan malware in their sample. How on earth has this become acceptable? The malware that has become particularly troublesome are the keyloggers. Keyloggers that track each keystroke made on your keyboard have become, we believe, the favorite tool used by hackers. According to the recent 2012 Verizon Data Breach Report, keyloggers were identified as the number one threat. Anti-Virus vendors all claim to prevent keyloggers. What they don't tell you is that they only prevent "known" and catalogued keyloggers, not the hundreds of thousands that have yet to be detected or thousands that are created every day.

"We believe that the big security vendors have been pushing the same technology for over 25 years," said George Waller, EVP of StrikeForce. "Yet every day and through our management's research, we found these technologies to be proven to be ineffective and easily breached. If you're in charge of security at your company and you're using anti-virus and tokens and you think you're safe, this should be your wake-up call."

"This week's reports should trigger every business owner and IT security executive to immediately re-evaluate their authentication and anti-keylogging strategy," says Waller.

StrikeForce's ProtectID® out-of-band authentication product enables organizations to leverage devices that people already own like mobile phones, making the total cost of ownership far less expensive and more secure than implementing tokens. StrikeForce's GuardedID® Anti-Keylogging Keystroke Encryption solution prevents undetected keyloggers from stealing user credentials and corporate data by encrypting each and every keystroke in real-time.

"Coverage of breaches is commonplace, but our management has found the discussion of solutions is non-existent from the big token and anti-virus vendors," added Waller. "We believe security vendors are asking you to buy an old technology that probably gets breached on a daily basis. We know what their technologies can do. If you get breached, and, based on the reports cited, we agree you most likely will, it's your own responsibility if you do not enhance your security. Keystroke encryption and out-of-band authentication are far more effective tools. Your wake-up call should include enhancing your protection with StrikeForce's ProtectID and StrikeForce's GuardedID Anti-Keylogging Keystroke Encryption solution."

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Medical Marijuana Inc. (OTCBB: MJNA) Shareholder Update - Dixie Elixirs Licensing Expansion

Orlando, FL 6/27/12 (StreetBeat) -- Medical Marijuana Inc., (OTCBB:MJNA) a leading hemp industry innovator, is pleased to update its shareholders on the status of its portfolio company, Red Dice Holdings and the Dixie family of products.

Recently, the Company acquired the licensing rights to the Dixie Elixirs brand through its portfolio company Red Dice Holdings, a company designed to license and market Dixie's family of products. Medical Marijuana Inc., owns 60% of Red Dice Holdings.

About Dixie
Dixie Elixirs (www.dixieelixirs.com) is a Denver-based firm which specializes in the production and distribution of food, beverages and other products infused with medicinal cannabis. Dixie Elixirs has been highly successful in providing health and wellness products to the Colorado marketplace for the past 3 years. Recently, Dixie launched "Dixie X", which is a new line of non-THC Hemp-based Cannabidiol (CBD) infused products.

The Dixie Elixirs and Edibles family of products consist of eight distinct and carefully formulated product lines of well over fifty five unique medicinal hemp infused products. This product portfolio includes medicated beverages and tonics, hemp capsules, medicated lozenges and edibles, as well as a full line of topicals and salves as part of the Dixie botanicals line of products which was recently featured on National Geographic's series American Weed.

As one of the worlds most recognized medicinal hemp brands, the Dixie products are available throughout Colorado at over 450 licensed locations, where medical cannabis products are sold. Dixie focuses on the development of innovative and socially acceptable products and continues to develop or acquire new products to expand their overall portfolio.

Expansion Plans
Within 60 days, Red Dice Holdings will launch on-line sales of the CBD based Dixie X and CanChewproducts in the US through licensed distribution companies. Selected international distribution will follow later this year. Hemp-based CBD products are legal in the United States and studies have shown them to be effective in treating a variety of medical conditions including pain management, anxiety, nausea and convulsions. The CBD health and wellness industry is estimated to be a $5 billion market.

For more information regarding CBD-infused products, see the following article:
MMJ CBD Infused Products Article

Within 90 days, Red Dice Holdings will enter into exclusive agreements to license the Dixie Elixirs brand, formulations, proprietary extraction processes, delivery methods, equipment and other intellectual property to carefully selected distribution partners in California, Arizona and Washington D.C. The agreements will include all of the Dixie products including Dixie X andCanChew gum.

According to the published See Change Strategy report, the medical cannabis industry is estimated to be a $1.7 billion market in 2012. Colorado, California and Arizona are estimated to account for 93% or approximately $1.6 billion. Red Dice Holdings will expand the Dixie brand throughout the remaining states and countries where medical cannabis is legal by continuing to develop exclusive licensing agreements.

To support the expansion initiatives, MJNA will launch a major marketing and public awareness campaign within the next 60 days to promote the Dixie and CanChew portfolio of products.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Unisys (NYSE: UIS) Gets Homeland Security Job Worth Up To $3B; Shrs Spike

Palm Beach, FL 6/27/12 (StreetBeat) -- Unisys (NYSE: UIS) shares are trading sharply higher Wednesday morning after the company said it has received a contract from the Department of Homeland Security to complete work under related to public safety communications systems. The contract includes a two-year base period and up to three one-year government optional extensions. The pact is worth up to $3 bilion over five years, the company said.

“This award gives Unisys an opportunity to provide mission-critical tactical communications systems support services to a broad range of federal agencies,” Marty Mackes, vice president for Homeland Security at Unisys Federal Systems, said in a statement.

UIS shares are getting a lift from the news: the stock is up $1.31, or 8.3%, to $17.07.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Wednesday Sector Laggards: Auto Dealerships, Vehicle Manufacturers

Palm Beach, FL 6/27/12 (StreetBeat) -- In trading on Wednesday, auto dealerships shares were relative laggards, down on the day by about 2.4%. Helping drag down the group were shares of O’reilly Automotive (Nasdaq:ORLY), off about 18.4% and shares of Advance Auto Parts (NYSE:AAP) down about 4.1% on the day.

Also lagging the market Wednesday are vehicle manufacturers shares, down on the day by about 1.3% as a group, led down by Kandi Technolgies (Nasdaq:KNDI), trading lower by about 6.2% and Tata Motors Limited (NYSE:TTM), trading lower by about 2.6%.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly

Zoom Tech (Nasdaq: ZOOM) Signs 400k Mobile Phone Order

Northern, WI 6/27/12 (StreetBeat) -- Zoom Technologies, Inc. (Nasdaq:ZOOM), a leading China-based manufacturer of mobile phones and other mobile electronic products, today announced that the company has signed an agreement with Viettel Mobile of Vietnam for original design and manufacturing (ODM) of mobile phones, and for Zoom to provide technical support to Viettel to set up its first R&D center and manufacture facility for mobile phones in Vietnam. The agreement includes Viettel placing an initial order of 400,000 units of ODM phones.

Headquartered in Hanoi, Viettel is the largest mobile operator in Vietnam capturing over 40% of the local market. Viettel is also among of the fastest growing telecom operators in the world with annual revenues doubling for each of five consecutive years from 2005 to 2010. Viettel currently has operations in six markets in Asia, Latin America and Africa, covering a total population of nearly 170 million people. In 2011, Viettel's revenue reached US$ 6 billion with 60 million subscribers worldwide.

Engineering teams from Zoom and Viettel will be working closely to design and manufacture the right handsets for the Vietnamese market and beyond. Eventually, the phones will be manufactured locally while Zoom is looking forward to continuing to supply more advanced products such as the Android-based smart phones for Viettel's markets. The initial order of 400,000 units will be designed and manufactured by Zoom using the Spreadtrum 6620 chip set, and delivery is expected to begin in July 2012.

About Zoom Technologies, Inc.

Zoom Technologies is a holding Company with subsidiaries that engage in the manufacturing, research and development, and sale of electronic and telecommunication products for the latest generation mobile phones, wireless communication circuitry and related software products. Zoom Technologies' subsidiary, Jiangsu Leimone, owns a majority stake of TCB Digital, which offers highly customized and high quality electronic manufacturing service for original equipment manufacturer customers as well as manufacturing its own brand of products under the ZOOM, LEIMONE and LONGTEL brand names. The Company's products are both exported globally and sold domestically in People's Republic of China.

Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.

StreetBeat Disclaimer

Distributed by Viestly